286 related articles for article (PubMed ID: 27777975)
1. The role for neutrophil extracellular traps in cystic fibrosis autoimmunity.
Skopelja S; Hamilton BJ; Jones JD; Yang ML; Mamula M; Ashare A; Gifford AH; Rigby WF
JCI Insight; 2016 Oct; 1(17):e88912. PubMed ID: 27777975
[TBL] [Abstract][Full Text] [Related]
2. Dissociation of systemic and mucosal autoimmunity in cystic fibrosis.
Theprungsirikul J; Skopelja-Gardner S; Meagher RE; Clancy JP; Zemanick ET; Ashare A; Rigby WFC
J Cyst Fibros; 2020 Mar; 19(2):196-202. PubMed ID: 31262645
[TBL] [Abstract][Full Text] [Related]
3. "NETtling" the host: Breaking of tolerance in chronic inflammation and chronic infection.
Skopelja-Gardner S; Jones JD; Rigby WFC
J Autoimmun; 2018 Mar; 88():1-10. PubMed ID: 29100671
[TBL] [Abstract][Full Text] [Related]
4. Anti-neutrophil cytoplasmic antibodies (ANCA) against bactericidal/permeability-increasing protein (BPI) and cystic fibrosis lung disease.
Mahadeva R; Dunn AC; Westerbeek RC; Sharples L; Whitehouse DB; Carroll NR; Ross-Russell RI; Webb AK; Bilton D; Lomas DA; Lockwood CM
Clin Exp Immunol; 1999 Sep; 117(3):561-7. PubMed ID: 10469063
[TBL] [Abstract][Full Text] [Related]
5. Pseudomonas-induced lung damage in cystic fibrosis correlates to bactericidal-permeability increasing protein (BPI)-autoantibodies.
Carlsson M; Eriksson L; Erwander I; Wieslander J; Segelmark M
Clin Exp Rheumatol; 2003; 21(6 Suppl 32):S95-100. PubMed ID: 14740434
[TBL] [Abstract][Full Text] [Related]
6. Systemic levels of anti-PAD4 autoantibodies correlate with airway obstruction in cystic fibrosis.
Yadav R; Yoo DG; Kahlenberg JM; Bridges SL; Oni O; Huang H; Stecenko A; Rada B
J Cyst Fibros; 2019 Sep; 18(5):636-645. PubMed ID: 30638826
[TBL] [Abstract][Full Text] [Related]
7. Anti-neutrophil cytoplasmic antibodies directed against the bactericidal/permeability-increasing protein (BPI) in pediatric cystic fibrosis patients do not recognize N-terminal regions important for the anti-microbial and lipopolysaccharide-binding activity of BPI.
Schultz H; Csernok E; Schuster A; Schmitz TS; Ernst M; Gross WL
Pediatr Allergy Immunol; 2000 May; 11(2):64-70. PubMed ID: 10893006
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis.
Zhao MH; Jayne DR; Ardiles LG; Culley F; Hodson ME; Lockwood CM
QJM; 1996 Apr; 89(4):259-65. PubMed ID: 8733512
[TBL] [Abstract][Full Text] [Related]
9. BPI-ANCA is expressed in the airways of cystic fibrosis patients and correlates to platelet numbers and Pseudomonas aeruginosa colonization.
Hovold G; Lindberg U; Ljungberg JK; Shannon O; Påhlman LI
Respir Med; 2020; 170():105994. PubMed ID: 32843162
[TBL] [Abstract][Full Text] [Related]
10. BPI-ANCA Provides Additional Clinical Information to Anti-Pseudomonas Serology: Results from a Cohort of 117 Swedish Cystic Fibrosis Patients.
Lindberg U; Carlsson M; Hellmark T; Segelmark M
J Immunol Res; 2015; 2015():947934. PubMed ID: 26273683
[TBL] [Abstract][Full Text] [Related]
11. Scorpionfish BPI is highly active against multiple drug-resistant
Holzinger JM; Toelge M; Werner M; Ederer KU; Siegmund HI; Peterhoff D; Blaas SH; Gisch N; Brochhausen C; Gessner A; Bülow S
Elife; 2023 Jul; 12():. PubMed ID: 37461324
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies directed against bactericidal/permeability-increasing protein in patients with cystic fibrosis: association with microbial respiratory tract colonization.
Aebi C; Theiler F; Aebischer CC; Schoeni MH
Pediatr Infect Dis J; 2000 Mar; 19(3):207-12. PubMed ID: 10749460
[TBL] [Abstract][Full Text] [Related]
13. Extensive endoscopic image-guided sinus surgery decreases BPI-ANCA in patients with cystic fibrosis.
Aanaes K; Rasmussen N; Pressler T; Segelmark M; Johansen HK; Lindberg U; Høiby N; Carlsson M; Wieslander J; Buchwald C
Scand J Immunol; 2012 Dec; 76(6):573-9. PubMed ID: 22946777
[TBL] [Abstract][Full Text] [Related]
14. Low-Avidity Autoantibodies against Bactericidal/Permeability-Increasing Protein Occur in Gram-Negative and Gram-Positive Bacteremia.
Theprungsirikul J; Thaden JT; Wierzbicki RM; Burns AS; Skopelja-Gardner S; Fowler VG; Winthrop KL; Martin IW; Rigby WFC
Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32747603
[TBL] [Abstract][Full Text] [Related]
15. Autoantibody response to BPI predict disease severity and outcome in cystic fibrosis.
Carlsson M; Eriksson L; Pressler T; Kornfält R; Mared L; Meyer P; Wiik A; Wieslander J; Segelmark M
J Cyst Fibros; 2007 May; 6(3):228-33. PubMed ID: 17166780
[TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa in cystic fibrosis: pyocyanin negative strains are associated with BPI-ANCA and progressive lung disease.
Carlsson M; Shukla S; Petersson AC; Segelmark M; Hellmark T
J Cyst Fibros; 2011 Jul; 10(4):265-71. PubMed ID: 21463973
[TBL] [Abstract][Full Text] [Related]
17. Expression and antimicrobial function of bactericidal permeability-increasing protein in cystic fibrosis patients.
Aichele D; Schnare M; Saake M; Röllinghoff M; Gessner A
Infect Immun; 2006 Aug; 74(8):4708-14. PubMed ID: 16861658
[TBL] [Abstract][Full Text] [Related]
18. BPI-ANCA and long-term prognosis among 46 adult CF patients: a prospective 10-year follow-up study.
Lindberg U; Carlsson M; Löfdahl CG; Segelmark M
Clin Dev Immunol; 2012; 2012():370107. PubMed ID: 23346184
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil extracellular traps exert both pro- and anti-inflammatory actions in rheumatoid arthritis that are modulated by C1q and LL-37.
Ribon M; Seninet S; Mussard J; Sebbag M; Clavel C; Serre G; Boissier MC; Semerano L; Decker P
J Autoimmun; 2019 Mar; 98():122-131. PubMed ID: 30704942
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies against bactericidal/permeability-increasing protein (BPI-ANCA) in cystic fibrosis patients treated with azithromycin.
Rotschild M; Elias N; Berkowitz D; Pollak S; Shinawi M; Beck R; Bentur L
Clin Exp Med; 2005 Jul; 5(2):80-5. PubMed ID: 16096858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
